Patrick N. Harter's Avatar

Patrick N. Harter

@tnonc-harter-lab.bsky.social

Neuropathologist Ludwig-Maximilians-University Munich, Germany Translational NeuroONCology Group @LMU_Muenchen @LMU_Uniklinikum #glioma #melanoma #brainmetastasis

150 Followers  |  82 Following  |  8 Posts  |  Joined: 15.11.2024  |  1.7361

Latest posts by tnonc-harter-lab.bsky.social on Bluesky

Post image

Looking forward to Maastricht 2025
ecnp2025.nl

29.05.2025 18:02 — 👍 1    🔁 0    💬 0    📌 0
View of Neurooncology: 2025 update | Free Neuropathology

www.uni-muenster.de/Ejournals/in...

Nice overview of Top Ten Papers in Neurooncology 2024 in #freeneuropathology and proud that our work on Brain metastasis is included! Thanks to all the fantastic collaborators and to #freeneuropathology

30.03.2025 08:12 — 👍 3    🔁 0    💬 0    📌 0

In some aspects it is already 5 past 12 but anyway Never too Late to adjust the clockwork. This is a fantastic Initiative by many great colleagues and Friends! 💪🏽 Thank you!!! Check out aufstehenfuerdemokratie.de

08.02.2025 08:02 — 👍 10    🔁 2    💬 1    📌 0

Excited to collaborate with @hoheyn.bsky.social, @jcnietos.bsky.social, @paulanietog.bsky.social & team on leptomeningeal metastatic disease - a key challenge in #NeuroOncology. Our study reveals unique immune responses in CSF, highlighting CSF liquid biopsy’s potential to guide CNS tumor therapies.

29.01.2025 12:33 — 👍 10    🔁 3    💬 1    📌 0
Preview
CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival - Acta Neuropathologica Communications Despite multidisciplinary local and systemic therapeutic approaches, the prognosis for most patients with brain metastases is still dismal. The role of adaptive and innate anti-tumor response includin...

www.cell.com/cancer-cell/...

CD74 !!!
This is Colon and this is what we found in Brain metastasis some years ago with @piazeiner.bsky.social 👍🏽

actaneurocomms.biomedcentral.com/articles/10....

17.01.2025 15:55 — 👍 8    🔁 1    💬 0    📌 0
Preview
PhD position translational program of clinical study on glioblastoma (experimental/computational) The experimental and computational doctoral position (3 years, TV-L E13 65%) is located in the AI-assisted therapy decisions in oncology group (Prof.

PhD position translational program of clinical study on glioblastoma (experimental/computational) supported by DKH. Lively research community and supervised by Prof. Kristian Unger, AI-Professor at LMU Munich and myself.
Looking forward to your applications !
euraxess.ec.europa.eu/jobs/306276

11.01.2025 08:37 — 👍 6    🔁 0    💬 1    📌 0
Preview
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours - Nature A study reporting the results of a clinical trial co-administering the GDF-15-blocking antibody visugromab with the anti-PD-1 antibody nivolumab demonstrates that neutralizing GDF-15 can overcome resi...

www.nature.com/articles/s41...

Overcoming ICI resistance. Great translation of basic research. Congratulations to all authors and special thanks to Jörg Wischhusen for his dedication to this project!

07.01.2025 22:12 — 👍 4    🔁 0    💬 0    📌 0
Preview
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients - Acta Neuropathologica Communications The gold standard for precise diagnostic classification of brain tumors requires tissue sampling, which carries relevant procedural risks. Brain biopsies often have limited sensitivity and fail to add...

actaneurocomms.biomedcentral.com/articles/10....

Somatic Copy Number Alterations in CSF cfDNA. Great collaboration lead by Pia S. Zeiner and Team @loewe-fci.bsky.social

20.11.2024 17:29 — 👍 4    🔁 1    💬 0    📌 0

Thank you! Best Pat

19.11.2024 10:56 — 👍 0    🔁 0    💬 0    📌 0

@tnonc-harter-lab is following 20 prominent accounts